Back To: Home



October 8 - November 10, 2014

October 27-29, 2014

More Events
Name:
Company:
Email:
 
 
 

ACADIA, Allergan extend ophthalmic collaboration
April 2012
SHARING OPTIONS:

SAN DIEGOŚACADIA Pharmaceuticals Inc. announced the extension of its drug discovery and development collaboration with Allergan Inc., which began in March 2003. The collaboration, which is centered on the discovery of therapeutics for glaucoma and other ophthalmic indications, has been extended one year to go through March 2013. During the extension period, Allergan and ACADIA will jointly pursue ophthalmic research. Allergan is entitled to exclusively license specific chemistry and related assets for development and commercialization, and ACADIA will receive research funding as well as potential license fees and milestone payments if certain agreed-upon clinical and regulatory milestones are met. ACADIA also stands to receive royalties on worldwide future product sales. The companies have two other collaboration agreements in effect, which have progressed to clinical programs in chronic pain and glaucoma.

Back








CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.